Figure 2 summarizes the obtained meta-analysis results comparing serum visfatin levels in NAFLD vs. controls, biopsy-proven NAFLD vs. controls, and ultrasound evaluated hepatic steatosis vs. controls. The gene discussed is NAMPT; the disease is fatty liver disease.